Valeant Pharmaceuticals International, Inc.
8,00 $ – 50,00 $
CASE STUDY. From 2008 to 2015, Valeant Pharmaceuticals International Inc. (Valeant) was a Wall Street darling under the leadership of CEO Michael Pearson. The company’s stock price soared as Pearson went on an acquisition spree.
